Bio-Rad to Place $250M in Private Notes

May 19, 2009

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories said today that it plans to offer $250 million in a private overseas debt offering to raise funds for working capital, and general corporate purposes, including acquisitions.

The company said that the $250 million aggregate senior subordinated notes will be offered only to qualified institutional buyers and may not be sold inside the United States.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Last of the Northern White Rhinoceroses, Sequenced

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

DNA Phenotyping Allowed in Bavaria

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Thanks for the Stress, Dad

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

This Week in Science

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Main menu